<DOC>
	<DOCNO>NCT01229241</DOCNO>
	<brief_summary>The aim study assessment systemic absorption local anesthetic continuous epidural infusion postoperative pain control .</brief_summary>
	<brief_title>Assessment Systemic Pharmacokinetics Levobupivacaine Ropivacaine During Continuous Epidural Infusion</brief_title>
	<detailed_description>In literature systemic toxicity bupivacaine widely demonstrate , like minor toxicity levobupivacaine ropivacaine anesthetic potency . The actually study human confront levobupivacaine ropivacaine aspect efficacy toxicity.The aim study assessment systemic absorption local anesthetic continuous epidural infusion postoperative pain control . Primary outcome : Assessment plasmatic equimolar concentration levobupivacaine ropivacaine continuous epidural infusion Secondary outcome : Assessment safety level local anesthetic ( major difference haematic concentration local anesthetic neuro-cardiotoxic dose ) . Difference analgesic efficacy levobupivacaine ropivacaine . Differences collateral effect due local anesthetic : hypotension sensitive block . Prospective randomize double-blinded clinical trial</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<criteria>ASA I ASA II Scheduled major surgery write informed consent ASA III , IV Emergency surgery Recovery intensive care unit surgery habitual opioid consumption cognitive mental alteration coagulopathy piastrinemia &lt; 100.000/mm3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>local anesthetic</keyword>
	<keyword>epidural</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>plasmatic concentration</keyword>
	<keyword>epidural continuous infusion</keyword>
</DOC>